详情页 - 河北医科大学第四医院机构库

当前位置：首页 > 详情页

Nivolumab-caused hyperprogression of diffuse large B-cell lymphoma of the testis and spontaneous remission of type 2 diabetes mellitus in an elderly patient: a case report.

11| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Department of Medical Oncology,The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China [2]Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

出处：

DOI：

ISSN：

摘要：

Nivolumab has been used in a variety of advanced malignant tumors. Cases of autoimmune diabetes associated with Nivolumab therapy have been reported gradually in recent years. This article reported a case of primary testicular lymphoma in an elderly patient with type 2 diabetes mellitus (T2DM). After treatment with Nivolumab, the primary disease was hyperprogressive disease but the blood glucose was relieved for a long time. Nivolumab may relieve the previous T2DM in diffuse large B-cell lymphoma patients; the potential mechanism needs to be further explored. Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

语种：

WOS：

PubmedID：

中科院分区：

出版当年[2021]版：

大类 | 4 区医学

小类 | 4 区肿瘤学 4 区药学

最新[2025]版：

大类 | 4 区医学

小类 | 4 区肿瘤学 4 区药学

JCR分区：

出版当年[2021]版：

Q4 ONCOLOGY Q4 PHARMACOLOGY & PHARMACY

最新[2023]版：

Q3 ONCOLOGY Q3 PHARMACOLOGY & PHARMACY

影响因子： 1.8 最新[2023版] 1.9 最新五年平均 2.389 出版当年[2021版] 2.384 出版当年五年平均 2.248 出版前一年[2020版] 2.3 出版后一年[2022版]

第一作者：

第一作者机构： [1]Department of Medical Oncology,The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

通讯作者：

通讯机构： [1]Department of Medical Oncology,The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China [*1]Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, Hebei 050000, China

推荐引用方式(GB/T 7714)：

APA：

MLA：